26839-77-0 (R-马来酸噻吗洛尔,(R)-(+)-Timolol Maleate)

马来酸噻吗洛尔;右旋噻吗洛尔马来酸盐;(+)-3-[3-(叔丁基氨基)-2-羟基丙氧基]-4-吗啉基-1,2,5-噻二唑马来酸盐;(R)-Timolol马来酸(噻吗洛尔杂质A 马来酸盐);(R)-马来酸噻吗洛尔;

D-Timolol maleate;(+)-3-[3-(tert-butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazole maleate;(+)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole hydrogen maleate;(R)-(+)-Timolol maleate;(R)-Timolol hydrogen maleate;2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (+)-, maleate (1:1) (salt), (-)- (8CI);2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2R)-, (2Z)-2-butenedioate (1:1) (salt) (9CI);Timclol Maleate;TiMolol Maleate iMpurity;(R)-Timolol maleate;R-enantiomertimolol maleate;78U14B243Y;(+)-Timolol maleate;Timolol maleate, R-enantiomer;Dextimolol Maleate;SPECTRUM1500578;HMS500I20;C17H28N4O7S;HMS1921E15;NSC757351;O649;AB0016571;Q27266692;(R)-Bis(3-(3-(tert-butylamino)-2-hydroxypropoxy)-4-mo;(R)-Bis(3-(3-(tert-butylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole) maleate;(Z)-but-2-enedioic acid;(2R)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;Pharmakon1600-01500578;TIMOLOL MALEATE, (R)-;NCGC00094794-01;NCGC00094794-02;50929-98-1;CCG-39272;(Z)-BUT-2-ENEDIOIC ACID, (2R)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLIN-4-YL-1,2,5-THIADIAZOL-3-YL)OXY)PROPAN-2-OL;J369.187J;EINECS 248-034-7;TIMOLOL MALEATE, R-ENANTIOMER [WHO-DD];TIMOLOL MALEATE, (+)-;J-019136;(2R)-1-((2-METHYL-2-PROPANYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL (2Z)-2-BUTENEDIOATE (1:1);(R)-(+)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole Hydrogen Maleate;EINECS 256-854-1;(R)-bis[3-[3-(tert-butylamino)-2-hydroxypropoxy]-4-morpholino-1,2,5-thiadiazole] maleate;WLRMANUAADYWEA-ASSQPYIHSA-N;(2R)-1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL (2Z)-2-BUTENEDIOATE SALT;2-PROPANOL, 1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-, (+)-, MALEATE (1:1) (SALT), (-)-;UNII-78U14B243Y;2-PROPANOL, 1-((1,1-DIMETHYLETHYL)AMINO)-3-((4-(4-MORPHOLINYL)-1,2,5-THIADIAZOL-3-YL)OXY)-, (2R)-, (2Z)-2-BUTENEDIOATE (1:1);26839-77-0;

MFCD09838437

WLRMANUAADYWEA-ASSQPYIHSA-N

1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m1./s1

S1N=C(C(=N1)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H])OC([H])([H])[C@@]([H])(C([H])([H])N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])O[H].O([H])C(/C(/[H])=C(/[H])\C(=O)O[H])=O

248-034-7

2934999090

为一新的强效β受体阻断药，对β1和β2受体都有阻断作用，作用强度为普萘洛尔的8倍，无膜稳定作用，无内源性拟交感活性，无直接抑制心脏作用，有明显的降低眼压作用。